Barbara Mora

University of Milan — Italy

Medicine · Health Sciences

26h-index5.0kcitations154works5.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Myeloproliferative Neoplasms: Diagnosis and Treatment(80), Kruppel-like factors research(33), Celiac Disease Research and Management(32), Acute Myeloid Leukemia Research(29), Chronic Myeloid Leukemia Treatments(28)

Publications154 total

The influence of patient engagement and self-efficacy on self-care in myeloproliferative neoplasms: A mediation analysis
European Journal of Oncology Nursing·2025Open Access
CD44 Participates to Extramedullary Haematopoiesis Onset by Mediating the Interplay Between Monocytes and Haematopoietic Stem Cells in Myelofibrosis
Journal of Cellular and Molecular Medicine·2025Open Access
<i>CALR</i> -mutated myeloproliferative neoplasms
Leukemia & lymphoma/Leukemia and lymphoma·2025· 2 cited
Personalized Transplant Decision Model for Myelofibrosis
Transplantation and Cellular Therapy·2025
Cytopenic overt primary myelofibrosis at presentation: Analysis of outcomes in the prospective, real‐world ERNEST‐2 registry
HemaSphere·2025· 1 citedOpen Access
Dengue virus in Texas
The Southwest Respiratory and Critical Care Chronicles·2025Open Access
Validity and Reliability of the Self‐Care in MyeloProliferative Neoplasms Inventory (SC‐MPNI)
European Journal of Cancer Care·2025· 1 citedOpen Access
Prognostic and Predictive Models in Myelofibrosis
Current Hematologic Malignancy Reports·2024· 9 citedOpen Access
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms
Leukemia·2024Open Access
Proposals for revised International Working Group–European LeukemiaNet criteria for anemia response in myelofibrosis
Blood·2024· 20 citedOpen Access
Editorial: Biological and clinical implications of the mutational landscape in myeloproliferative neoplasms
Frontiers in Oncology·2024· 2 citedOpen Access
Targeting exhausted cytotoxic T cells through <scp>CTLA</scp>‐4 inhibition promotes elimination of neoplastic cells in human myelofibrosis xenografts
American Journal of Hematology·2024· 10 citedOpen Access
Clinical impact of mutated <scp>JAK2</scp> allele burden reduction in polycythemia vera and essential thrombocythemia
American Journal of Hematology·2024· 24 citedOpen Access
Validation and molecular integration of the RR6 model to predict survival after 6 months of therapy with ruxolitinib
Haematologica·2024· 4 citedOpen Access
Molecular characterization of diffuse large B‐cell lymphomas associated with hepatitis C virus infection
British Journal of Haematology·2024· 4 citedOpen Access
Investigation of Serum Albumin as a Dynamic Treatment-Specific Surrogate for Outcomes in Patients With Myelofibrosis Treated With Ruxolitinib
JCO Precision Oncology·2024· 4 citedOpen Access
Using real-world evidence in haematology
Best Practice & Research Clinical Haematology·2024· 4 citedOpen Access
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes
Annals of Hematology·2023· 17 citedOpen Access
Chromosome 9p Duplication Promotes T-Cell Exhaustion and Enhances Stem Cell Clonogenic Potential in JAK2-Mutant Myeloproliferative Neoplasms
Blood·2023Open Access
A Population-Based Study on Survival of 652 Higher Risks Myelofibrosis Patients Treated with Ruxolitinib in Italy
Blood·2023Open Access
page 1 of 8Next →

Frequent Co-authors

Francesco Passamonti(26), Paola Guglielmelli(16), Alessandro M. Vannucchi(16), Margherita Maffioli(15), Maria Cristina Mazzilli(14), Elisa Rumi(14), Tiziano Barbui(14), Alessandro Rambaldi(13), Francesca Megiorni(13), Marianna Caramella(12), Francesca Palandri(11), Margherita Bonamico(11), Jean‐Jacques Kiladjian(10), Valerio De Stefano(10), Giulia Benevolo(10), Toni Giorgino(9), Rami S. Komrokji(8), Jason Gotlib(8), Francisco Cervantes(8), Michele Merli(8)